Skip to main content

Table 2 Correlation between the clinicopathological features and expression of miR-216

From: MiR-216b inhibits cell proliferation by targeting FOXM1 in cervical cancer cells and is associated with better prognosis

Patient characteristics miR-216 expression P-value
Low High
Age (years) ≤55 36 40 0.627
>55 39 35
FIGO stage I, II 10 41 < 0.001
III, IV 65 34
Histology Squamous 54 67 = 0.012
Others 21 8
Survival status Alive 9 46 < 0.001
Dead 66 29
  1. Patient number of miR-216b-low and miR-216b-high groups and the corresponding proportion (%) were shown. The clinicopathological differences between miR-216b-low and miR-216b- high groups were analyzed using Pearson’s χ2 test